100763
论文已发表
提 交 论 文
注册即可获取Ebpay生命的最新动态
注 册
IF 收录期刊
- 3.3 Breast Cancer (Dove Med Press)
- 3.4 Clin Epidemiol
- 2.5 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.5 Clin Interv Aging
- 4.7 Drug Des Dev Ther
- 2.7 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.5 Int J Women's Health
- 2.5 Neuropsych Dis Treat
- 2.7 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.3 Ther Clin Risk Manag
- 2.5 J Pain Res
- 2.8 Diabet Metab Synd Ob
- 2.8 Psychol Res Behav Ma
- 3.0 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.7 Risk Manag Healthc Policy
- 4.2 J Inflamm Res
- 2.1 Int J Gen Med
- 4.2 J Hepatocell Carcinoma
- 3.7 J Asthma Allergy
- 1.9 Clin Cosmet Investig Dermatol
- 2.7 J Multidiscip Healthc
西藏危重症患者静脉血栓栓塞症的风险评估与预防：一项前瞻性队列研究并设历史对照
Authors Qiong J, Gu Y, Dekyi J, Dawa, Tsring P, Zhao M, Wang X, Li G, Liu H
Received 5 August 2024
Accepted for publication 28 March 2025
Published 3 April 2025 Volume 2025:18 Pages 1171—1179
DOI http://doi.org/10.2147/RMHP.S490160
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Jongwha Chang
Ji Qiong,1,* Yanmei Gu,2,* Jampa Dekyi,1 Dawa,1 Phurbu Tsring,1 Min Zhao,1 Xin Wang,2 Guangming Li,2 Haixia Liu2
1Department of Critical Care Medicine, Lhasa People’s Hospital, Lhasa, 850000, People’s Republic of China; 2Department of Critical Care Medicine, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Haixia Liu, Department of Critical Care Medicine, Beijing Youan Hospital, Capital Medical University, 8 Xi Tou Tiao, You An Men Wai Street, Fengtai District, Beijing, 100069, People’s Republic of China, Tel +86 13521206692, Email liuhx2024hx@163.com
Objective: Venous thromboembolism (VTE) is a significant concern in critically ill patients. However, the incidence and risk factors of VTE in high-altitude regions like Tibet remain unclear. This study aimed to assess the effectiveness and safety of standardized anticoagulation therapy in preventing VTE among intensive care unit (ICU) patients in Tibet.
Methods: This prospective controlled study included 78 patients in the treatment group receiving low molecular weight heparin (LMWH) and 56 patients in the control group without standardized VTE prophylaxis. VTE incidence, risk factors, and safety outcomes were compared between the two groups. Patients were followed up for a minimum of one week after ICU discharge to assess VTE outcomes.
Results: The incidence of VTE was significantly lower in the treatment group (35.9%) compared to the control group (42.9%, p< 0.05). Risk factors for VTE included mechanical ventilation. The most common VTE type observed was deep vein thrombosis (DVT), with pulmonary embolism (PE) occurring less frequently. No significant bleeding events were observed in the treatment group.
Conclusion: Standardized LMWH prophylaxis effectively reduces VTE incidence in critically ill patients in Tibet without increasing bleeding risk. Regular risk assessment and appropriate prophylaxis should be implemented in high-altitude ICU settings.
Keywords: venous thromboembolism, critical care, thromboprophylaxis, high altitude, Tibet
